Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.35 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 3/20 | 0.32 |
| ▸ | DDB1 | Q16531 | 2/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6551912 | 0.91 | HSD17B10 (0.39) | NPC1CYP19A1NLRP3HSD17B10ALDH1A1 | |
| SCHEMBL1517935 | 0.91 | PRKCA (0.41) | NPC1CYP19A1 | |
| SCHEMBL977159 | 0.82 | MAP3K14 (0.38) | NPC1CYP19A1LMNAMAPTMEN1 | |
| SCHEMBL2099423 | 0.81 | PRKCA (0.47) | NPC1CYP19A1 | |
| SCHEMBL180318 | 0.80 | PRKCA (0.49) | — | |
| SCHEMBL3628006 | 0.80 | PRKCA (0.49) | — | |
| SCHEMBL1332286 | 0.79 | NPC1 (0.36) | NPC1CYP19A1LMNAMAPTMEN1 | |
| SCHEMBL11095324 | 0.79 | NPC1 (0.36) | NPC1CYP19A1LMNAMAPTMEN1 | |
| SCHEMBL1886945 | 0.78 | NLRP3 (0.34) | NPC1NLRP3HSD17B10ALDH1A1 | |
| SCHEMBL20589363 | 0.77 | PRKCA (0.38) | CYP19A1LMNAMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113214959-B | Chip for separating and capturing Ewing sarcoma circulating tumor cells | 深圳市儿童医院 | 2022-08-26 | — | — | CN | claimed |
| CN-112391263-B | Neuroblastoma circulating tumor cell capturing chip and manufacturing method thereof | 深圳市儿童医院 | 2022-05-27 | — | — | CN | claimed |
| EP-2971064-B1 | PROXIMITY ASSAY FOR IN SITU DETECTION OF TARGETS | VENTANA MED SYST INC (US) | 2019-10-16 | — | — | EP | claimed |
| EP-4441079-B1 | SWITCHABLE POLYPEPTIDE AND ITS USE FOR GENTLE AFFINITY PURIFICATION | UNIV OXFORD INNOVATION LTD (GB) | 2026-02-11 | — | — | EP | disclosed |
| EP-4655590-A1 | MODIFIED IMMUNO-MOLECULAR ASSAY FOR FASTER BIOMARKER DETECTION | BIOMERIEUX (FR) | 2025-12-03 | — | — | EP | disclosed |
| WO-2025245282-A1 | COMPOSITIONS AND METHODS FOR DETECTION OF PROTEIN ANALYTES | RANGE BIOTECHNOLOGIES, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| US-12466861-B2 | Polypeptide with enhanced rate of spontaneous isopeptide bond formation with its peptide tag partner and uses thereof | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2025-11-11 | — | — | US | disclosed |
| US-20250333455-A1 | POLYPEPTIDE AND ITS USE IN AFFINITY PURIFICATION | UNIV OXFORD INNOVATION LTD (GB) | 2025-10-30 | — | — | US | disclosed |
| US-20250327129-A1 | COMPOSITIONS AND METHODS FOR DETECTION OF OVARIAN CANCER | MERCY BIOANALYTICS INC (US) | 2025-10-23 | — | — | US | disclosed |
| US-20250297317-A1 | COMPOSITIONS AND METHODS FOR DETECTION OF LIVER CANCER | MERCY BIOANALYTICS, INC. | 2025-09-25 | — | — | US | disclosed |
| US-20250223649-A1 | COMPOSITIONS AND METHODS FOR DETECTION OF LUNG CANCER | MERCY BIOANALYTICS, INC. | 2025-07-10 | — | — | US | disclosed |
| US-20220119459-A1 | PROTEINS AND PEPTIDE TAGS WITH ENHANCED RATE OF SPONTANEOUS ISOPEPTIDE BOND FORMATION AND USES THEREOF | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2022-04-21 | — | — | US | disclosed |
| CN-108368538-B | Method for generating proximity probes | 欧凌科蛋白质公司 | 2022-03-29 | — | — | CN | disclosed |
| US-6001580-A | DETECTING THE ACTIVATED ISOFORM OF MITOGEN ACTIVATED KINASE; CONTACTING SAMPLE WITH AN ANTIBODY WHICH BINDS AN AMINO ACID SEQUENCE, CONTACTING SAMPLE WITH SECOND ANTIBODY, DETECTING ACTIVE ISOFORM WHICH SPECIFICALLY BINDS TO BOTH ANTIBODIES | TAKEDA CHEMICAL INDUSTRIES, INC. (JP) | 1999-12-14 | — | — | US | disclosed |
| EP-0735370-A1 | Method for assaying map kinase | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-10-02 | — | — | EP | disclosed |
| US-5534414-A | Process for preparing conjugates consisting of a specific binding partner and a carbohydrate-containing protein | BEHRINGWERKE AKTIENGESELLSCHAFT (DE) | 1996-07-09 | — | — | US | disclosed |
| EP-0394297-A4 | ANTI-RETROVIRAL AGENT | — | 1990-12-27 | — | — | EP | disclosed |
| WO-1990013562-A1 | CHEMICALLY MODIFIED CD4 PEPTIDE FRAGMENTS HAVING ANTI-RETROVIRAL PROPERTIES | GENELABS INCORPORATED (US) | 1990-11-15 | — | — | WO | disclosed |
| EP-0394297-A1 | ANTI-RETROVIRAL AGENT | GENELABS, INCORPORATED (US) | 1990-10-31 | — | — | EP | disclosed |
| WO-1989003813-A1 | ANTI-RETROVIRAL AGENT | GENELABS INCORPORATED (US) | 1989-05-05 | — | — | WO | disclosed |